Update on the release date of eCTD specification package (v 1.0) and implementation
We wish to inform stakeholders that the timeline for releasing the eCTD specification package (version 1.0) has been adjusted to Q3 2024 according to the system testing schedules. Additional testing is required to ensure the functionality and smooth transition to the eCTD platform. To allow sufficient time for stakeholders to familiarise with version 1.0, the target eCTD implementation date will be adjusted accordingly.
HSA will provide regular updates on the progress of eCTD implementation, and we seek your understanding on the unforeseen delay. We will work closely with our industry stakeholders to ensure a successful deployment of the eCTD system.
To assist industry stakeholders who are new to eCTD submissions, we have prepared some tips for selecting an eCTD software vendor to facilitate the company’s transition to eCTD.
eCTD (electronic common technical document) is the standard structured format for the electronic transfer of regulatory information related to therapeutic products from industry to health authorities. eCTD submissions minimise the need for using storage media such as CD/DVD ROMs for dossier submissions. It also allows better product life cycle management for both industry and HSA.
HSA will adopt a phased approach for eCTD implementation for therapeutic product submissions based on ICH eCTD specification 3.2.2.
Further guidance on eCTD submissions will be published closer to the target implementation date (estimated Q1 2025). Bookmark this page for the latest updates or subscribe to HSA announcements.
Contact Us
For more information on eCTD submissions, please email us at HSA_TP_ectd@hsa.gov.sg